Legal and Ethics Concerns of Psilocybin as Medicine.
The journal of the American Academy of Psychiatry and the Law December 12, 2024 Stephanie M Schonholz, Jacob M Appel, Harold J Bursztajn et al. 3 citations
Psilocybin shows promise as a treatment for psychiatric illnesses, but its federal illegality in the U.S. complicates access and regulation despite state-level decriminalization efforts. This article reviews current legal regulation, standard of care, right to effective treatment, and the respectable minority doctrine. It discusses ethical issues including provider bias, patient-provider dynamics, informed consent, and equity and access that psychiatrists must consider as psilocybin access expands for research.